Skin Tech Pharma Group obtains MDSAP Certification.
With this, the company takes a giant leap in its international projection.
Skin Tech Pharma Group has just obtained the MDSAP (Medical Device Single Audit Program) certification in Australia, Brazil, and Canada for its flagship product, RRS® HA Long Lasting.
The MDSAP certificate is a single audit program for medical devices to verify compliance with high standard quality management requirements. In this specific case, it guarantees Skin Tech Pharma Group’s adherence to the regulatory demands of these countries.
This marks a milestone in the trajectory of Skin Tech Pharma Group as a medical device manufacturer, because the MDSAP certification facilitates the commercialization of RRS® HA Long Lasting in Australia, Brazil, and Canada. It also provides a seal of trust for both regulatory authorities and consumers in the three countries.
The MDSAP certification obtained by Skin Tech Pharma Group demonstrates the company’s commitment to patient safety and the effectiveness of its products. It also highlights that Skin Tech Pharma Group’s international expansion and prestige, with its flagship RRS® HA Long Lasting, are a reality.
